Paying users zone. Data is covered by hidden.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

Microsoft Excel LibreOffice Calc

Biogen Inc. (BIIB)


Common-Size Income Statement

Difficulty: Beginner

Biogen Inc., Common-Size Consolidated Income Statement

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Product, net hidden hidden hidden hidden hidden
Revenues from anti-CD20 therapeutic programs hidden hidden hidden hidden hidden
Other hidden hidden hidden hidden hidden
Revenues hidden hidden hidden hidden hidden
Cost of sales, excluding amortization and impairment of acquired intangible assets hidden hidden hidden hidden hidden
Gross profit hidden hidden hidden hidden hidden
Research and development hidden hidden hidden hidden hidden
Selling, general and administrative hidden hidden hidden hidden hidden
Amortization and impairment of acquired intangible assets hidden hidden hidden hidden hidden
Collaboration profit sharing hidden hidden hidden hidden hidden
Acquired in-process research and development hidden hidden hidden hidden hidden
Restructuring charges hidden hidden hidden hidden hidden
Gain (loss) on fair value remeasurement of contingent consideration hidden hidden hidden hidden hidden
TECFIDERA litigation settlement charge hidden hidden hidden hidden hidden
Gain on sale of rights hidden hidden hidden hidden hidden
Income from operations hidden hidden hidden hidden hidden
Interest income hidden hidden hidden hidden hidden
Interest expense hidden hidden hidden hidden hidden
Gain (loss) on investments, net hidden hidden hidden hidden hidden
Foreign exchange gains (losses), net hidden hidden hidden hidden hidden
Other, net hidden hidden hidden hidden hidden
Other income (expense), net hidden hidden hidden hidden hidden
Income before income tax expense and equity in loss of investee, net of tax hidden hidden hidden hidden hidden
Income tax expense hidden hidden hidden hidden hidden
Equity in loss of investee, net of tax hidden hidden hidden hidden hidden
Net income hidden hidden hidden hidden hidden
Net (income) loss attributable to noncontrolling interests, net of tax hidden hidden hidden hidden hidden
Net income attributable to Biogen Inc. hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03), 10-K (filing date: 2015-02-04).

Item Description The company
Income from operations The net result for the period of deducting operating expenses from operating revenues. Biogen Inc.’s income from operations as a percentage of revenues declined from 2016 to 2017 but then slightly increased from 2017 to 2018.
Income before income tax expense and equity in loss of investee, net of tax Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Biogen Inc.’s income before income tax expense and equity in loss of investee, net of tax as a percentage of revenues declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.
Net income attributable to Biogen Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Biogen Inc.’s net income attributable to Biogen Inc. as a percentage of revenues declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.